Key statistics
On Friday, Harvard Bioscience Inc (HBI:DUS) closed at 0.41, 78.26% above the 52 week low of 0.23 set on May 08, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.412 |
|---|---|
| High | 0.412 |
| Low | 0.41 |
| Bid | 0.396 |
| Offer | 0.432 |
| Previous close | 0.41 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 44.72m |
| Free float | 41.03m |
| P/E (TTM) | -- |
| Market cap | 21.17m USD |
| EPS (TTM) | -1.28 USD |
Data delayed at least 15 minutes, as of Mar 13 2026 18:31 BST.
More ▼
- Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
- Harvard Bioscience Announces Reverse Stock Split
- Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
- Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
- Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
- Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
- Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
- Harvard Bioscience Announces Third Quarter 2025 Financial Results
- Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
- Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
More ▼
